THC
Tenet Healthcare Corporation
Mentions (24Hr)
0.00% Today
Reddit Posts
A Drug Test Cost a D.E.A. Agent His Job. He Sued, and Got It Back
Florida Senate Committee Unanimously Passes Bill To Restrict Hemp-Derived Products With New THC Limits
Cannabis Stocks: Squeeze to the moon when DEA reschedules THC...
Curaleaf Expands Zero Proof™ Brand Portfolio with Launch of Stir Fast-Acting THC Beverage Mix
Florida GOP Lawmaker Files Bill To Cap Marijuana At 10% THC If Voters Approve Legalization Ballot Measure
DEA Calls For Even More THC, Psilocybin And DMT To Be Produced For Research In 2024
Missouri Bills Would Regulate Hemp-Derived Delta-8 THC Like Marijuana
$SAPX NEWS OUT Seven Arts Entertainment Announces Feature Film Production Agreement
States That Ban Marijuana May ‘Unintentionally Promote’ Unregulated Delta-8 THC Products, Federally Funded Study Finds
$MIRA trading at $3.80 - valuation of $22.70 based on DCF analysis
$MIRA trading at $3.80 - valuation of $22.70 based on DCF analysis
Big Weed today is a whole lot like Big Tobacco in the 1950s
Three Small Caps to Consider for Outsized Returns $ICS $NEVI $PMED
NEVIS BRANDS INC. Announces Licensing Agreement and Expansion of Major™ brands to Michigan (CSE: NEVI)
NEVIS BRANDS INC. Announces Licensing Agreement and Expansion of Major™ brands to Michigan (CSE: NEVI)
Tilray Brands Expands Cannabis Beverage Portfolio With New THC, CBG and CBD Drink Innovations by Top-Performing Canadian Brands
Tilray Brands Expands Cannabis Beverage Portfolio With New THC, CBG and CBD Drink Innovations by Top-Performing Canadian Brands
Tilray Brands Expands Cannabis Beverage Portfolio With New THC, CBG and CBD Drink Innovations by Top-Performing Canadian Brands
Stanford grads created a hangover-free alternative to beer: THC beverage
Three Small Caps to Consider for Outsized Returns $ICS $NEVI $PMED
Seven Arts Entertainment Inc. Enters Letter of Intent to Acquire Film and Music Production Company
Will the cannabis of the future be brewed in big vats of yeast?
Nevis Brands eyes further expansion for Major after strong 3Q sales (CSE:NEVI)
Nevis Brands Reports Financial Results for Q3 2023 (CSE: NEVI)
Nevi Brands Reports First Quarter Profit as a Newly Listed Cannabis Company (CSE: NEVI)
Nevis Brands Reports Financial Results for Q3 2023 (CSE: NEVI)
MariMed’s Betty’s Eddies™ Introduces Limited-Edition THC and CBG Infused Sweater Weather Betty’s for the Cozy Fall Season
Trulieve Announces Progress on First Ever Pharmacy Sales of Low-THC Oil in Georgia
Nevis Brands eyes further expansion for Major after strong 3Q sales (CSE:NEVI)
Nevi Brands Reports First Quarter Profit as a Newly Listed Cannabis Company (CSE: NEVI)
Nevi Brands Reports First Quarter Profit as a Newly Listed Cannabis Company (CSE: NEVI, PSCBF, 8DZ)
Nevis Brands may have cracked the code to a successful cannabis beverage (CSE:NEVI)
Sibannac, Inc. Provides Update on Operations
Nevis Brands locks in license agreement with Blaze Life Holdings (CSE:NEVI)
LP Performance Highlights from the Legislative Review of the Canadian Cannabis Act
NEVIS BRANDS INC. Announces Licensing Agreement and Expansion of Major™ brands to California (CSE: NEVI)
$JSDA Jones Soda Releases New Special Edition Orange Chocolate Flavor
Jones Soda Expands THC-Infused Soda Line To Washington State Dispensaries
Been a tough week for most folks, from EBET, SDC,INPX MCOM...We all need something to rewind and recover. And SPRC might just do it.
NEVIS BRANDS INC. Announces Expansion of Major™ brands to Nevada (CSE: NEVI)
Tilray CEO teases THC-infused beer upon U.S. cannabis legalization
New Cannabis Brand with Significant Upsides : Nevis Brands (CSE:NEVI)
MariMed’s Bubby’s Baked Introduces New THC-Infused Blueberry Muffin Bites to Start the Day On a High Note
"Enchanted Elixirs: Mastering Potions and Terpenes"
"From Forbidden Forests to Legal Gardens: Harry Potter's Journey to Declassify Cannabis"
Sibannac, Inc. Announces Revenue Through Sales of Its Kratom Energy Shot with New York City and Las Vegas Distribution
Hot Picks: Penny stocks in Marijuana and AI - Your watchlist!
Vext Science, Inc. (OTC: VEXTF/ CSE: VEXT) this pup has BARK!
NEVIS A Uniquely Profitable Consumer Brands Company Operating In The Cannabis Space (CSE: NEVI)
NEVIS Brands : a Breath of Fresh Air in a Cannabis Beverage Sector (CSE: NEVI)
CLS Holdings USA, Inc. 2023 CEO Address to Shareholders CLSH
CLS Holdings USA, Inc. 2023 CEO Address to Shareholders
Sibannac, Inc. Appoints Karl Gottschalk - Manufacturing Automation Engineer and Operational Expert - as CEO of its Subsidiary, Immersive Brand Concepts, Inc.
$TLRY - Medical Cannabis Oil May Help Cancer Patients...
$LFLY - Medical Cannabis Oil May Help Cancer Patients...
$SNNC News out. Sibannac, Inc. Appoints Karl Gottschalk - Manufacturing Automation Engineer and Operational Expert - as CEO of its Subsidiary, Immersive Brand Concepts, Inc.
DEA Considers Delta-8 THC Products Federally Illegal When Synthesized From CBD, Official Says In Newly Revealed Email
A year from now, TLRY has the potential to quadruple your investment.
Minnesota's low-dose THC beverage market is booming
Two Potential Small Caps Revolutionizing The Health-Tech Space But Only One Winner (CSE: PMED, OTCQB: PMEDF) (CSE: BLO, OTC PINK: BLOZF)
CapitalGainsReport: 4 Penny Stocks With Skyrocket Potential ( $EPAZ, $PPCB, $AGFY, $BJDX)
Ontario Cannabis Store joins calls to raise Canada's THC edibles cap
Predictmedix (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) An Advanced Health Tech Play Using Artificial Intelligence Triage Settings
CapitalGainsReport: 4 Penny Stocks With Skyrocket Potential (EPAZ, PPCB, AGFY, BJDX)
A technology penny stock that I think is very promising and why
U.S. Forest Service Says State Marijuana Legalization Drives ‘Uptick’ In Positive THC Tests For Federal Workers As Perceptions Have ‘Shifted Dramatically’
Third Round of Consumer Testing Strongly Validates Rapid Absorption and Effectiveness of Pressure BioSciences UltraShear Processed Nano-THC Oral Spray
FYI, the ABCs of CBD from the DEA, FDA, and HHS - Rules still TBD for THC
The Georgia Board of Pharmacy is meeting today to consider allowing pharmacies to sell low THC cannabis products.
Medicinal cannabis is a 'life-changing treatment' for people with Tourette syndrome
Competition Bureau recommends changing THC limits for edibles, easing pot packaging
(imo) Hemp Loophole makes MSOs uninvestable
Predictmedix Developed an AI-Driven Comprehensive Triage Solution (CSE: PMED, OTCQB: PMEDF, FRA:3QP)
Government-Funded THC-Rich Cannabis Strains Debut In Argentina: Why This Could Shake Up Marijuana Markets
Why I Believe Charlotte's Web CBD Is About To Be Acquired by British American Tobacco or Organigram (DD inside)
DEA Official Says New Rules Are Coming For Synthetic Cannabinoids, Including CBD And Delta-8 THC
Why Predictmedix is a potential ten-bagger (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP)
Understanding Cannabis Extraction: Methods and Processes
Solei Brand Debuts Premium CBD, CBN and THC Infused Tea Collection
Cannabis Startups Try AI for Everything From Dabbing to Driving Tests
Cartel Blue, Inc. has announced its intention to file a Regulation A offering.
Extended Consumer Testing Strongly Validates Market Transforming Speed and Dosing Efficiency of Pressure BioSciences UltraShear Processed Nano-THC Oral Spray
IS AI IMPAIRMENT TESTING NEXT FOR CANNABIS? (CSE:PMED)(OTCQB:PMEDF)
Texas House Passes Bill To Allow Medical Marijuana As An Opioid Alternative And Replace THC Limit, Sending It To Senate
Texas House Approves Bill To Allow Medical Marijuana As Opioid Alternative And Replace THC Limit
Texas House Will Vote Next Week On Allowing Medical Marijuana As Opioid Alternative And Replacing THC Limit
NBA Deal Would Remove THC Drug Testing, Allow Player Investment in MJ Companies
THC: one of the better Health Stocks
Mentions
> [As for cannabis drinks expanding to sporting events and other arenas, Schepp [general manager of beverage at Green Thumb Industries] said it was “going to take a little bit more discussion with some of the sport leagues, because the NHL does not currently want THC products sold at their games”, but added he was hopeful “that stance will change” in the near future.](https://www.theguardian.com/us-news/2026/jan/28/chicago-united-center-cannabis-drinks)
[Whirlwined](https://www.prnewswire.com/news-releases/whirlwined-introduces-the-worlds-first-non-alcoholic-hemp-derived-delta-9-thc-infused-wine-302665657.html) announced they were launching the first true non-alcoholic wine infused with hemp THC the other day. This was in Chicago, where we have seen beverages get a carve-out. >Whirlwined is real wine—fully fermented, then gently de-alcoholized.... I have mentioned before that I think non-alcoholic beer and wine haven't hit the market yet because even though they don't have alcohol in them, non-alcoholic wine/beers start out as alcoholic products. So they are still regulated by the TTB. Whirlwined was the only wine product listed at Binny's Beverage Depot. However they did have one non-alc beer product listed. So I was looking into that to see if it was really a beer. It isn't. But the company that makes the "beer" product does explicitly [describe the issue with the TTB and cannabis drinks](https://gobrewing.com/blogs/insights-and-misadventures/can-beer-have-thc?srsltid=AfmBOopz7OEx0Cs1EC4fCZ1-d2nDnEs3Pkq4iPVAP6zPH54rYfYq8Gh-). >**Why Beer Can’t Contain THC** >In the U.S., beer is regulated by the Alcohol and Tobacco Tax and Trade Bureau (TTB)......The TTB will not approve any formulas or labels for alcohol beverage products that contain a controlled substance under federal law. Since cannabis is still a controlled substance under federal law, the TTB prohibits mixing THC with any beverage classified as beer. >Even non-alcoholic (NA) beers fall under [TTB jurisdiction](https://gobrewing.com/blogs/insights-and-misadventures/why-some-na-beers-have-alcohol) because they are brewed like traditional beer before alcohol is removed. That means they also cannot legally contain THC. If a beverage is marketed as NA beer, it’s subject to the same restrictions. >So, while you might see THC seltzers or cannabis-infused tonics on the market, **you won’t find a true “THC beer.” The moment a drink is legally considered beer, THC is off the table.** >But wait... >For a drink to be considered beer under TTB regulations, it has to be made with traditional brewing grains—like barley or wheat. >But at Go Brewing, **we offer a gluten-free beer that is brewed with alternative ingredients, which makes this brew outside of the scope of regulation of the TTB**. So while their beer brand isn't actually a real beer, we did just get a company marketing what they say is a true non-alcoholic wine with THC? Does this signal the TTB has eased this stance regarding non-alcoholic beer and wine?
Yea that's what I was initially thinking. If there are people drinking a CBD/THC beverage at NBA games, the NBA will want it to be whichever one they end up doing a sponsorship deal with. Or it could just be an insurance/liability thing. The major sports leagues might have stricter liability requirements for their events vs what the arena has for their own events. Or it could be because sports teams have broadcasting deals with major networks that might have issues seeming to be advertising THC beverages on national broadcasts.
This is fantastic. As much as I enjoy gummies, drinks are a far more enjoyable social experience. Smoking is too but I’m doing less and less of that as I get older to focus on health. I cannot wait for 1 or 2 mg THC drinks to be sold everywhere like alcohol. I can have a few, get a little buzz, and have great social time the same as I used to with alcohol.
From the PR: >"United Center guests can now enjoy Señorita and RYTHM (RYM) hemp-derived THC drinks at the majority of concerts, shows, and special events...." I don't think NBA and NHL games fall into these categories. Deceptive? Probably. Fraudulent? Probably not.
Even a broken clock is right twice a day. THC beverages will never break a 5% share, and basically every company that will invest in the segment will regret it. There will be 1 or 2 large scale low cost producers that will be financial viable, while the rest will eat negative margins for years before eventually divesting
I'll have to go dig up the quotes, but pretty sure Can't Trust was teasing some other sort of big beverage partnership after they partnered with Breakthru. I wonder if it could've been Boston Beer's planned entry point, but after the fake walls happened Boston Beer ended up partnering with Entourage Health. That's pure speculation, but I keep looking for GTI/RYM connections to Boston Beer, given the public interest from Ben and Boston Beer's interest in moving their current THC beverage into the US hemp market. I know Breakthru is one distributor for Boston Beer, but not sure how deep their relationship goes.
A couple other thoughts. A little over a year ago, the chair of the newly formed Coalition for Adult Beverage Alternatives was on a podcast discussing hemp beverages. They talked about how on-premise consumption and event venues were things they were most excited about. One of the things they said they needed to figure out (and were close to doing so) was the insurance issues that would come up. If a major event venue like the United Center is selling them, there must have been something figured out regarding insurance. Lots of insurance companies are involved with lobbying for cannabis and cannabis banking. Also as a more minor observation, it's good to see the United Center is comfortable selling a THC beverage that contains caffeine. If anyone here partakes, you are aware that THC+caffeine (aka the hippy speedball) is one of the best combinations of mood altering substances. I think it's a potentially huge market segment (energy drinks, coffee, etc.) but I am worried there could be residual worry from the Four Loko days regarding mixing caffeine with anything intoxicating.
The stock price doesn’t reflect the upside potential of $RYM. Still as bullish as ever. If THC drinks aren’t completely banned (I don’t think they will be, despite the narrative) this is way bigger and more scalable than any Retail MSOS. THC drinks are the real money maker and $RYM will be one of the Top Players in the industry
This kind of partnership could bring more visibility to RYTHM, but it's essential to consider the broader trends in the THC beverage space. If the excitement doesn't translate into consistent sales, we might see a reality check soon. For those tracking performance, here’s a link to analyze the data: https://aimytrade.io/ticker/RYTHM?utm_source=reddit&utm_medium=comment&utm_campaign=weedstocks.
It's interesting to see the carve out for hemp THC. This is definitely a sign of things to come. It looks like big alcohol's(along with smaller craft breweries) foray into hemp/thc drinks will be the next big play. As much as I dislike Tilray from an investment perspective, I am now thinking of opening up a small position, just for this play. Glta
The hemp THC ban/it's possible reversal or further delay is probably their biggest concerns. "no med card THC" smoke shops are everywhere in Florida; if those get outlawed under federal law, AG/DeSantis will have to do something about it unless hemp pays them big. Which is still possible because it's their 2nd biggest market after Texas.
My sister-in-law goes to a book club where they usually bring wine. At a recent one someone brought a THC drink mix. And I have personally brought THC drinks to multiple occasions, where people who don't drink much chose them instead of the alcohol that was there.
> Wine is a particularly interesting category, because apparently a strong market for THC beverages right now are "wine moms" who like to have a drink after the kids go to bed My household can vouch for this
Whirlwined announced a few days ago that they were launching the first real [non-alcoholic wine with hemp THC](https://www.prnewswire.com/news-releases/whirlwined-introduces-the-worlds-first-non-alcoholic-hemp-derived-delta-9-thc-infused-wine-302665657.html) starting in Chicago. They are launching at Binny's Beverage Depot. If you go to Binny's website they do have a very wide selection of THC brands, including most or all of the brands by the biggest cannabis companies (TLRY/RYM/etc.). However as they say, Whirlwined is the [only product in the "non-alcoholic wine" category](https://www.binnys.com/extras/thc/?refinementList%5BproductVarietal%5D%5B0%5D=THC%20Non-alcohol%20Wine). I had heard in podcasts and such that real wine/beer offerings were supposed to be hitting the hemp THC category soon. There aren't really any at this time to my knowledge. Everything is seltzers/mocktails/sodas/tea/etc. Wine is a particularly interesting category, because apparently a strong market for THC beverages right now are "wine moms" who like to have a drink after the kids go to bed. I'm not sure if its [legality or emulsions](https://www.reddit.com/r/weedstocks/comments/1op0xya/comment/nneqxpb/?utm_source=share&utm_medium=web3x&utm_name=web3xcss&utm_term=1&utm_content=share_button) that are the reason non-alcoholic wine and beers haven't been on the THC market. It will be interesting to see if more products like these start popping up as big alcohol looms over the market.
Definitely an interesting move by Chicago. Keep an eye on how this impacts the broader market, especially with consumer sentiment shifting toward regulated products. I like to check in on the data here: https://aimytrade.io/ticker/THC?utm_source=reddit&utm_medium=comment&utm_campaign=weedstocks.
You’re just focusing on the DUI aspect of this thing and getting hung up. There are many corporations that have a Zero tolerance policy for THC. You haven’t changed my mind on it, just because there isn’t a scientifically accepted threshold for impairment doesn’t mean that there won’t be one in the future. It takes companies like this to push the standards further. You also don’t have to invest in it, but this company is going to grow whether you are on board or not.
> [ICYMI: Chicago passes intoxicating hemp ban w a THC drink carve out. Hmmm 🤔 $RYM $GTBIF 🇺🇸](https://x.com/Bkov9/status/2014441235352846691)
> Hemp-derived THC drinks are not included and can still be sold at stores with licenses to sell liquor, part of a compromise to move the ordinance forward. Some CBD products made from hemp, like creams and ointments, are also exempt. Cannabis products can still be sold in state-licensed dispensaries.
Detection window ≠ impairment. THC doesn’t behave like alcohol, and there’s still no scientifically accepted threshold that proves impairment at the time of driving. Breath tests can’t account for tolerance, edibles’ delayed effects, or oral contamination from recent use (terpenes, full-spectrum CBD, residue). Blood tests can’t be done roadside, and courts already toss THC DUI cases for weaker evidence than this. Until impairment can be directly and reliably proven, defense attorneys will absolutely have a field day.
Canada doesn't allow beverages in regular retail like alongside alcohol. The US has shown in multiple states and in multiple types of businesses that if you put cannabis beverages alongside alcohol they sell very well. Bars and liquor stores report much much more than 1% of their sales being THC beverages once they started carrying them.
Why I am so glad you brought this up, Courts already toss cases when THC testing is unreliable. In DuPage County, IL, 19 marijuana DUI charges were dropped because blood tests couldn’t reliably measure impairment. ([abc7chicago.com](https://abc7chicago.com/post/dupage-county-states-attorney-dismisses-marijuana-dui-charges-faulty-blood-tests-university-illinois-chicago-aftl/15851816/?utm_source=chatgpt.com)) Roadside marijuana breath tests face the same challenge — unless the science can clearly link THC levels to impairment, expect defense attorneys to have a *field day*, just like they always do with new, unproven cannabis testing tech.”
How so; and how is it any different from how they test now? Are attorneys having a field day now, when current testing can test positive for THC that was consumed a week ago?
I switched 100% to weed from alcohol a year ago, but I love beer. Fortunately, we're in a golden age of non-alcoholic, and water soluble THC is $14-$40 per bottle, and can last atleast a couple weeks of heavy regular use.
Here in Canada, I buy non-alcoholic beer and water-soluble THC drops. 1000x better than any pre-mixed beverage I've had.
THC concentrates. Don’t have any other stuff besides psychedelics
I see a niche, but in my experience drinking alcohol (at a bar/pub/club) will cause me to compulsively buy more alcohol. One slow onset THC drink will get me out of the bar/pub/club and to a grassy field to look at stars while I eat a Costco jar of M&Ms. not to say the business model can’t change, but consumption of THC and alcohol lead to v different margins for nightlife owners
If you have my metabolism, that would just make you see slightly brighter colors. Unless by edibles you meant 100mg THC per instead of 10mg, then yeah, 200mg should make you feel pretty good bro.
Finally got logged back into computershare - since their little blip and disappear - verified all my gme- and - AMC were still hanging on and will most likely decide to get more of THC —> tenet healthcare has been flying through the game with just enough activity to stay unnoticed - I have 232 shares of it and am not looking for any contracts in this one - she’s consistently made me 18% (55k ) last year and is already looking TITS ( • )( • )
I had a THC drink and leftover ice cream cake for dinner. Life is good!
Its a great stock to trade for sure. But holding might be extremely lucrative as well if THC drinks survive
I haven’t been here in a while boys. Just waiting for our time. Wanted to share something though, if you at all believe in THc drinks and don’t think they are actually getting nuked. $RYM and $GTBIF are going to the moon. There isn’t public data out there but it’s just me watching there store count for months and spending hours entering in zip codes to find there stores. They are expanding like crazy. Store count is growing at an unbelievable pace. Also Circle K has started selling the Drinks in more states besides Florida. The Rythm Drinks (not senorita) have definitely doubled stores in the last 2 months entering entirely new markets, like GA and IL. If THC drinks don’t get nuked the stock is going to fly. Honestly will probably do well just on next ER because of rapid growth
A week ago there was a sign at the pump of a Circle K near me in Ohio saying that they have THC products. I didn't investigate to see what they featured.
AB InBev added "differentiation of beer from cannabis and hemp in tax and regulation" to one of their lobbyists. They now have 4 of their lobbyists discussing hemp. https://lda.senate.gov/filings/public/filing/ea656674-a573-4857-be01-b2621d896ac4/print/ Circle K also rolled out hemp THC beverages in Texas a few days ago. Only brand I've seen them stocking so far is Varin. https://www.prnewswire.com/news-releases/circle-k-becomes-first-major-convenience-chain-in-texas-to-sell-thc-beverages-launching-with-varin-302660758.html
Stop spreading misinformation They don’t sell THC drinks anymore.
Found this on linkedin yesterday. >Policymakers and regulatory agencies must consider pathways that retain essential safety oversight while reducing redundant barriers to research. While DEA rescheduling to Schedule III may alleviate certain administrative and tax-related constraints, it does not, on its own, resolve the FDA, IRB, state-level, and manufacturing barriers that uniquely burden investigator-initiated cannabis research. For example, harmonizing DEA and state licensing requirements, reconsidering cannabis scheduling, expanding access to research-grade cannabis products (including isolates of naturally occurring and semi-synthetic THC-isomers currently not included in the NIDA Drug Supply Program), permitting the use of commercially available cannabis products authorized for sale under state regulatory frameworks, and modernizing the IND process for cannabinoids could dramatically lower the entry threshold for conducting meaningful human research. Until such reforms are implemented, a persistent gap will remain between widespread cannabis use and rigorously designed human research, reflecting the relative scarcity of controlled clinical studies needed to understand its health effects. https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.70195
Good article. I wouldn't get too excited in terms of industry opportunities, though. This is for very low dose oils only. >Medicinal cannabis will be administered orally in Spain, in doses...which may not exceed 32 milligrams per day (total THC)...and initially for only four indications: chronic pain, spasticity due to multiple sclerosis, severe forms of epilepsy, and nausea and vomiting due to chemotherapy.
Disagree. I think the long view is that big pharma will be doing a lot of research to develop and get approval for THC replacements for opiates. Think: Instead of Tylenol+Codine it’s Tylenol+THC. Instead of Demorol Or Morphine it’s a THC based drip. Instead of the meds they currently give at nursing homes to make that existence bearable it’s a THC based med. That’s the research I think they are talking about and that the US will take point on. That’s also where the big money will be for companies with a lot of grow space.
Agreed. You can buy CBD products at stores and through the medical program. I seriously doubt there's any additional market demand to also buy them at pharmacies. Especially when it would be CBD-only, without a trace of THC.
Good rational points greenbelieve and Kbarbs. My primary regret is not selling all my weedstocks the day before 18 Dec. I obviously did not realize how much of a STN event this actually would be. I am now left with waiting for the next bit of good news...the trick is now determining when STN kicks in next time (as in 12:50 pm on 18 Dec). Tilray's 8 Jan Q Report was pretty much what I expected (as I said "meh"). I have come to not expect much from any weedstock and am banking on S3 clarity news to provide a boost and hopefully an exit. FWIW, I am no longer a Tilray fan...tough to come to that conclusion after believing there would be some sort of Cinderella story here. I do believe it will benefit from any S3 clarity, but long term? Not sure how they will live down Simon's proven track record of share dilution for questionable acquisitions. Rest assured, when I finally sell my remaining shares of Tilray I won't be coming on here to trash the company...it is not my "duty" to warn others about this (or any other company). This subreddit has become such a buzz kill in this regard. There is the occasional enlightened post (most recently geologic's synopsis of CWEB) but mostly just trash talk. The sad truth is I actually strongly believe in CBD from a medical perspective (it changed my life as far as pain management of arthritis)...and this belief has interfered with making sound investment decisions in this sector. I do believe Tilray's medical distribution system in Germany is the best model. I am completely taken aback by the lack of understanding of the US government. The outright misinformation and lies about CBD and THC is hard to comprehend.But then, the concept of Greenland being invaded was inconceivable up to about a year ago. Canada becoming the 51st state is no longer an absurd thought (assuming Greenland becomes something like another Puerto Rico). The state of the world is the worst I have seen. I did not mean to slip into politics, but regardless of the movement on S3 by this government, I worry about what's to come in a way I have never worried before.
Exactly. Stocks are reacting to uncertainty more than fundamentals. Hemp operators found a window and cannabis companies are paying the price for a slower regulatory path. Until Congress clarifies total THC versus delta 9 this tug of war keeps going.
So 10000% no medical flower? 🔮 Got it. Doesn’t sound like S3 benefits MSOs at all! And Tilray supplies Pfizer with THC extract for drugs, imported from their GMP certified facilities. Sounds like a win! 😉
Beverages i meant was their “beverage division” which is 100% in USA. Almost all beer with a sprinkling of hemp THC
I personally don't think hemp beverages end up being banned at the end of a year. I feel like the alcohol industry mostly wanted either regulation or a short ban in order to regulate. Basically just push out any small players they don't like during the "ban" period. Trump is even calling for them to change the strict THC limit they pushed through, though in his framing it was for the full spectrum CBD industry.
Good follow up. Looks like that was just their non-THC non-CBD drink line that was launching in Sprouts though. So it would be pretty reasonable to assume Brez is another one of the seven brands that will be part of the THC beverage launch.
I haven't been following too closely, but why launch new products if the hemp loophole has been (in a year-ish)? Is there expectations that hemp-derived THC products will fall under different legislation or be affected by rescheduling in some way?
Can't find a non paywall link yet, but Sprouts Farmers Markets is launching hemp THC beverages in 120 stores across Texas and Florida starting Monday. It says they are carrying seven brands but i only see four named so far. Cann, Nowadays, Magic Cactus, and Nektr.
The more research I do into VFF the more it makes me think it’s probably the most effective and diversified operator in the cannabis space right now… - $35M mortgage debt tied to greenhouse facilities worth ~10x the debt; no financial debt and they aren’t using their credit facility. - $88M cash on hand, so essentially no net debt. - $389M annual revenue; $10.8M quarterly net profit diversified between cannabis and greenhouse grown vegetables. - 5.5M square feet of Texas greenhouse ready to convert to cannabis pending licensing (hopefully April 2026) - Canadian operations cash flowing and 700%+ growth in European operations. - Already trades on NASDAQ. I wish I had just gone all in on VFF a year ago… it has to be one of the most impressive business turnaround stories in any sector in 2025. Might still drop off a cliff if it can’t get its Texas license in April, but if it does, I think it could quickly become one of the top MSOS by 2030 in terms of market share. Also needs Schedule 3 and for the NASDAQ to loosen rules on THC-touching assets though I suppose.
They are lying though. Blood tests measure THC concentration very accurately. Breathe samples are not the best way - especially if it has to be analyzed at a lab anyway - just like blood. This may be good for employers but i don't see it useful for law enforcement in the field - which they claim would likely be their biggest customer?? Where do cops want a test that takes days to get results? How long do traffic stops take where you live?
The $1.5M net income in Q1 FY26 (ended Aug 2025) is real profitability after years of non-cash hits adjusted EBITDA +9%, record $210M revenue (+5%), and Canadian adult-use +12% YoY. Acquisitions helped diversify (beverages now huge), but cannabis growth is there too. On share: That Zuanic chart looks like annual/older data showing a dip from 13.3% (2023) to 9.3% (2025), but Tilray's Oct 17, 2025 release cites Hifyre National Sept 2025 as #1 by revenue with growing share QoQ and strongest growth among top producers. They lead pre-rolls, beverages (40%+ THC), oils, chocolate, flower by end-quarter. Market's fragmented; revenue/share gains are happening. 'Nobody enjoys'? Leading categories say otherwise. Sources: Q1 earnings: https://ir.tilray.com/news-releases/news-release-details/tilray-brands-reports-strong-first-quarter-fiscal-2026-results #1 position/growing share: https://ir.tilray.com/news-releases/news-release-details/tilray-brands-marks-seven-years-cannabis-legalization-canada-1 Q2 drops tomorrow so we will see who's right
Wyld bought Gron, combining two of the most prominent names in edible brands. Wyld says the purpose is to scale Gron while keeping them independent. I am wondering if this is a sign that there is confidence that low-dose hemp edibles will remain legal. Right now Wyld has a bit larger distribution of their products in retail, but they also sell a hemp version of their product with much larger distribution. Gron on the other hand, appears to be still selling exclusively in dispensaries, with a formulation based on cannabis. I feel like the one way this makes sense for Wyld to be able to scale Gron would be to switch Gron from their state-by-state cannabis model to a more uniform hemp model like Wyld is using in their hemp versions of their products. One of [Gron's comments](https://mjbizdaily.com/news/cannabis-pioneer-christine-apple-takeways-from-building-gron-edibles-business/404216/) from earlier in 2025: >Reporter: Looking ahead five to 10 years, what are the most significant shifts you anticipate in the cannabis edibles market? >Gron: .....We will see low-dose (hemp-derived THC) edibles on the open market. High-dose products will stay in dispensaries. More on manufacturing: >Because they’re able to manufacture in one location to support the entire country in Canada, they’re able to use more technology, more machinery, different machines for labeling, manufacturing, central mail system. **It really becomes like a regular product.** >In the U.S., we’re still doing things manually – not because we don’t want to invest in technology or machinery (but) because **we can’t duplicate (the process) in every state.** >We have different molds, different products and different packaging, and **we’re not allowed to ship anything.** It’s limited the technology we’ve been able to use. Just take Texas as an example. Gigantic state that is currently trying to regulate low dose hemp products. If I were a "cannabis-only" gummy maker, I would need to get a hemp product in the pipeline soon if I wanted to be selling throughout Texas.
**CBD/hemp opportunities internationally.** Markets that aren't going to be opening up to intoxicating THC anytime soon could open for hemp/CBD. Think of larger more conservative markets like India, where BAT has a major presence. Or even if they open up for medical cannabis, CWEB has a history of being a first mover in new low-THC medical markets. I assume a reason CWEB partnered with Tilray years ago was because at that time Tilray had the certifications/manufacturing capability CWEB would need to export CBD internationally. I know CWEB has had a deal for years with InterCure in Israel, where they will distribute CWEB products once Israel changes CBD laws. This was supposed to happen years ago. And Tilray used to export to InterCure themselves, so Tilray being the middleman for CWEB/InterCure makes sense. Tilray and CWEB were also both partnered with Southern Glazers for CBD distribution in the US in 2022, which never materialized. Since then Tilray has obtained more beverage assets, along with the distribution that comes with it. This is another area their partnership could benefit each other. **Hemp incorporated into the industrial market and carbon credit market.** Increasing your CBD margins by selling the byproducts of CBD production to fiber, food, fuel, and carbon markets. Lots of ex-Canopy people including Bruce Linton left Canopy to go pursue opportunities in this area. The best thing would be if hemp was part of our biofuel ecosystem imo. It's so much better than corn. Bruce Linton used to say that by the time you got to the point of extracting CBD, you should already have a profit from the other parts of the plant being upcycled into fiber and fuel. CWEB appointed Jessica Saxton as CFO right after BAT's investment. She came directly from AB InBev, where she was the CFO for their subsidiary that upcycled their spent grains from producing alcohol. If this sort of industrial hemp market is developed and supported, CBD really could be an incredible gold mine for major corporations. A highly regulated product so they can control it, but one that could cost almost nothing to produce and still demand a high price markup in a huge variety of CPG products.
Correct, which [I was also sure to point out](https://www.reddit.com/r/weedstocks/comments/1nte2kg/comment/ngt9uxj/?utm_source=share&utm_medium=web3x&utm_name=web3xcss&utm_term=1&utm_content=share_button) after the CBD video. With BAT involved, it seems like the most obvious thing would be for OGI to give them some Jupiter money or for BAT to invest more themselves. OGI has already followed up on investments that BAT had previously made, such as Open Book Extracts and Sanity Group. The amount of money CWEB would need to last a few quarters could be found in BAT's couch cushions. And right now BAT is actively investing into OGI to get to 50%, while they only have 20% of CWEB locked down. But regardless you would still need a path to profitability. Here are some options for CWEB: **CBD incorporated into the medical system.** This is being discussed with Medicare now. CWEB was a pioneer early CBD acceptance, as well as being the main driver behind Florida's initial medical cannabis program. Besides their history, they have their current joint venture with BAT that is in Phase 2 of FDA trials for CBD to treat autism. They have strains with a long history and strong patent protection. Lots of reasons to think they will be a winner in medical CBD. **CBD allowed as a dietary supplement.** This was a specific part of BAT's initial investment. I am pretty confident that hemp beverages are going to be regulated, so if that happens that means CBD is allowed in ingestible products by the FDA. CWEB has some of the best partnerships in the CBD industry such as BAT, Walmart, MLB, etc.. so they will be sure to get shelf space in key places. Right now major retail like Walmart don't sell ingestible CBD, which is where the big money is. Topicals aren't big sellers. Similar to how hemp beverages didn't sell until they were actually on shelves in retail, ingestible CBD should see large sales increases if they are in regular retail. **CBD supply partnerships in CPG/beverage.** If CBD is allowed in food/beverages, then besides CWEB selling their own CBD as a dietary supplement, this opens up the market for them to supply CBD to a major CPG company looking to expand into CBD. Or to supply CBD to new products being pushed by BAT. Besides the potential for CBD to be incorporated into tobacco/vape products, BAT has been expanding into several wellness/functional drink brands through their venture capital arm ([Btomorrow Ventures](https://www.btomorrowv.com/)). And CWEB was supposed to be releasing a CBD seltzer in late 2022, but never did. Instead they got their BAT investment. Makes more sense to supply CBD to another BAT brand than to try to launch a new CWEB drink brand. I definitely see a possibility that beverage brands like Celsius will have a CBD energy drink in the near future. Pepsi had a hemp oil Rockstar they were testing out in 2022. And back when Coke was rumored to be getting into CBD, one thing that was discussed was that very few (if any) companies could possibly supply CBD at scale and consistency that a company like Coke would need. Besides scale issues, there were also CBD emulsion issues in 2020. Idk I just feel like the big beverage/alcohol brands needed a few years, but they are now ready to make a serious move. THC beverages are mostly similar to one market segment (alcohol), but CBD beverages can cover a much wider range of actual market segments such as water, coffee, sports drinks, energy drinks, tea, etc.. CBD has a much larger addressable market than THC.
Some folks you just can’t reach. Better analogy: “I can’t get any more coffee, so I take these new THC gummies to help ease the withdrawal symptoms and combat the lethargy”
In addition to what u/No_Love_Gained said, Raj has been adament about bringing Canna Cabana retail stores the US for years now but can't until NASDAQ allows it. He's currently hinting about entering through a brand licensing model which they would later acquire. Personally I don't mind waiting. The US retail landscape is an absolute sh!t show given the state by state patchwork, years of price compression, and the recent rise of Hemp Delta-9 THC being sold at gas stations and major retailers. This made me question if entering the US as a cannabis retailer is a good idea AT ALL given the instability and unpredictability of the market. Assuming Delta-9 is no longer an issue, I hope high tide enters mature rec states like California or Colorado where there is no growing requirement and shows how well it's retail model handles competitive and mature markets, without getting caught up in all of the intricacies of being a producer. This is along the lines of what Raj has been hinting at all along.
The order is required for the April full spectrum CBD medicare project Trump promised Kessler. Can't have even trace amounts of THC, a schedule 1 substance in something being paid for my Medicare. If we rightly assume Bondi goes to a final ruling with a 30nday enactment period, that takes us to March just in time for the program to begin. This timeline also pair well with MH's info (which has been wrong before mind you).
Sharing my take of what is going down so people can throw rocks at it and tell me where/if I'm wrong * Market is pricing cannabis stocks like the EO was toothless and won't actually be completed (similar to Biden starting process but it never being completed). Also the industry is stuck in hype cycles and long retail always runs out of gas to sustain long runs of price appreciation * I don't believe the market is properly pricing in rescheduling (as per point above), however without follow through like banking reform and uplisting there won't be an appropriate re-rating of the stocks like longs are hoping for * As for timing, we have seen rumors that Trump wants this done by End of January. I believe this to be true as he promised his boy Kessler to allow full spectrum CBD coverage with Medicare by as early as April 1st (as per Dr Oz during the executive order signing). Full spectrum CBD includes THC and I don't believe Medicare is allowed to cover a S1 drug hence the rescheduling needs to happen soon * So timeline makes sense to Bondi to announce something end of January to give find 30 day rule that expires around March before April deadline * However I firmly believe SAM will file a lawsuit challenging the rescheduling process which would most likely delay this and cause volatility in the stock prices when announced. However both Shane Pennington and Alan Bronstein (ATACH President) have both implied SAM is fighting a losing battle with a lawsuit and they are both prepared to fight and are confident on this having minimal impact besides however long it delays things (obviously they have to say that to sound confident) * Also with this being an election year its difficult to get things passed in 2H of the year as politicians are on the campaign trail. So if Safe banking and uplisting isn't in the first half of the year we probably don't see it in 2026 in my opinion. Positioning myself to expect a rescheduling being announced for finalization at end of Q1, with a lawsuit that delays into Q2/3. Also looking for Safe banking/uplisting to get ball rolling in first half of Q1 shortly after rescheduling is finalized - DOJ finalized not after lawsuits. I also think rescheduling will have a halo effect as once this is done you will see more states turn on. I'm looking at VA/PA going rec, GA going more broad medical and maybe even North Carolina going medical. Taking the stigma out of S1 will allow more states to have more robust programs Purposely left out the Hemp ban out of this as I believe there will be a change to either carveouts or simply kicking the can down the road with an extension. Let me know what I've missed, where I'm wrong or what you would add to the thesis...
https://www.wsj.com/health/wellness/lower-back-pain-treatment-cannabis-fcf22d0e?st=McccSb&reflink=article_copyURL_share Now, two new studies provide some of the most comprehensive evidence yet that THC—the psychoactive compound in cannabis that creates the high—in combination with other parts of the cannabis plant may provide safe and effective relief. The two large, Phase 3 clinical trials demonstrated that the THC product is safe and more effective at reducing chronic lower back pain than placebo or opioids
If they did do away with the per container limit what is .3% of a 12 Oz soda? .036 ozs. So about 1 gram THC or 1000 milligrams? That sounds about right to me. This is a joke.
They haven't banned anything yet. Some of us expect hemp beverages to survive in whatever hemp ban is eventually finalized. Trump just told them to change the language surrounding total THC content. It was framed as a way to allow full spectrum CBD, but let's see what the total THC amount per container ends up actually being set at. That language change could easily permit low dose hemp product, like what Texas is pushing for. Pernod Ricard was in talks with hemp beverage company Brez a few months back. This was confirmed by Brez. So we know Pernod Ricard has been looking into a hemp acquisition.
That’s interesting. Jones sold off there, cannabis beverage line earlier this year, and I don’t need to tell you what recently happened to hemp THC so why would Pernod be interested?
According to new research published in Frontiers in Pharmacology, cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC) were found to interfere with the growth and spread of ovarian cancer cells. The findings come from a study led by Siyao Tong of Khon Kaen University. marijuana herald
It’s expected that tobacco/nicotine companies will get into weed/THC with the lifted restrictions
The test can tell if you have had THC in the past 24hrs…that doesn’t make you impaired. This machine will be no doubt challenged in a court of law.
THC of course! 4 hours of fun Especially when the kids wake up in a bad mood!
THC gummy and I wake up before everyone else! It is like a morning coffee and it helps because the girls in the family wake up in a bad mood! I bring the fun!
I appreciate the Marijuana Herald is not known for its accurate accountings...but this does fit with Dr. Oz suggesting Medicare support by April. I will be seeking out a more credible source and will share if I find anything: "President Trump has directed Attorney General Pam Bondi to issue a final ruling on marijuana rescheduling by the end of January, according to two sources close to the president who spoke with The Marijuana Herald. The executive order signed by Trump last week orders AG Bondi to “take all necessary steps to complete the rulemaking process related to rescheduling marijuana to Schedule III of the CSA in the most expeditious manner in accordance with Federal law”. Under federal law, any rescheduling decision must be finalized through DOJ, with coordination from the Department of Health and Human Services (the Department issued their rescheduling recommendation in 2023). Trump’s message to Bondi, as described by the sources, underscores that while the administration intends to follow the legal framework, it also expects a timely outcome rather than prolonged administrative delays. Although Trump ordered Bondi to issue a ruling “by the end of January”, it’s possible a ruling could come early in the month. If DOJ follows through with issuing a final rule on an accelerated timeline by the end of January, marijuana would be officially moved to Schedule III by the spring, a change that would formally acknowledge accepted medical use under federal law and significantly alter how the substance is treated for tax, research, and regulatory purposes. Schedule III status would not legalize marijuana federally, but it would eliminate the punitive tax provision known as 280E, expand opportunities for scientific research, and allow FDA-approved cannabis medicines to be prescribed nationwide (currently only CBD and synthetic THC can be prescribed). The push for a January deadline comes as pressure continues to build from lawmakers, industry stakeholders, and patient advocates who have been awaiting clarity since the rescheduling review began. A final ruling will mark the first change to marijuana’s federal classification since it was placed in Schedule I more than five decades ago. While DOJ has not publicly commented on the timeline, the president’s position suggests the administration wants the matter resolved quickly, setting the stage for a major shift in federal marijuana policy at the start of the year."
Not until Nov 2026, and the EO even calls this out, calling for congress to raise it's new THC cap on hemp products because even some full spectrum hemp derived CBD would be considered illegal under the new language > The Assistant to the President and Deputy Chief of Staff for Legislative, Political, and Public Affairs shall work with the Congress to update the statutory definition of final hemp-derived cannabinoid products to allow Americans to benefit from access to appropriate full-spectrum CBD products while preserving the Congress’s intent to restrict the sale of products that pose serious health risks.
Rescheduling need to be initiated by Bondi by the end of February. This allows a final ruling and 30 day shortened comment period. Trump buddy Kessler's CBD pilot program for seniors is scheduled to begin April 1. He won't let his golf buddy down. It included THC containing medicine, so rescheduling obviously needed. I expect a Bondi Memo to be released at around the same time, to allow cover / encourage of SAFE banking legislation.
I don't really have a specific exit plan. I was taking profits at the end of last week, but I still have an extremely large CWEB position. My original plan with them was that I was confident long term, but if things weren't looking great I would be able to get out on a significant pump when the Farm Bill was getting redone, as I have always been confident CBD would be legitimized further. So even if CWEB wasn't looking great, I was expecting some sort of CBD pump at some point. I'm still pretty confident in CWEB though, so I didn't exit that much of my position, and will wait and reload if cannabis/CBD falls out of the news cycle leading up to April. If so I'll look to re-invest some of my profits sometime in February I'm guessing, but I'll keep an eye out for other opportunities in the meantime. Hopefully it just continues to climb though and we won't have to worry about timing dips. Between their pharma ambitions and their potential retail expansion in places like Walmart, they have some of the highest upside in the sector imo. Products that are intoxicating like THC don't have nearly the reach of a product like CBD that can be implemented in all sorts of products. With the GOP's love of the supplement market, I just can't envision them not eventually classifying lower-dose CBD as a dietary supplement, which would be massive for CWEB.
Yeah it affects people differently as well. I quit THC a long time ago. It really only gives me anxiety and there’s no point in it. It also affects your short term memory and makes you not want to do anything all day.
THC isnt that great either. The withdrawal symptoms are terrible.
The only drug I have tried is THC so I don't how cocaine feels like and can't relate to characters or real people high on cocaine.
“You’ve tested positive for THC from 2 weeks ago, here’s your DUI” Police chief is getting his Christmas bonus 4 sure.
Wouldn’t the players making such beverages just switch to Weed THC infused drinks, wouldn’t that be a loophole?
But how many AUC of THC fragments is too many AUC of THC fragments, and who makes that decision? At some point we decided that 0.08 BAC was the max allowable for driving before becoming too impaired. Impaired judgment doesn’t work that way with THC because it metabolizes so much slower than alcohol. While the detection technology may be completely legitimate, although very little data is provided here, it does not in any way determine if someone is impaired.
There are PLENTY of companies manufacturing and selling S3 drugs that are listed, with bank accounts. Cannabis could EASILY be grown and processed as a SV drug... just at 10 to 15% THC. If it's not delisted, first.
It wouldnt be highly likely, they tend to avoid hard debt; and ultimately have products that rely on THC compounds. So Idk what other pharma or heath company that would have their eye on them.
Shitco that buys companies and can’t integrate a ham & Swiss sandwich Iconic beer brands that AB couldn’t hit numbers even after buying/forcing sellers to devote shelf space THC beverage demand will stay locally produced. If AB & MC think it’s safe, theyll dominate the mass market. This might be one of the most regarded attempts at DD
It’s clear that Trump thinks CBD=medicine and THC=drugs. The whole announcement was focused on CBD. I don’t think they mentioned THC once.
CBD farms have been leaning into their post-harvest test results since 2018, heat-treated to inactivate THC into CBN, without destroying the CBD. Not technically compliant with 2025-revised hemp definition, these CBD-focused farms are successfully pretending they weren't also using the 2018 delta-9 loophole. 2026 hemp loophole will be non-enforcement by claiming "this is a CBD crop, haven't tested it lately because we aren't harvesting yet."== Final product is compliant.
> Furthermore, recent federal legislation just effectively banned 95% of hemp-derived THC competition (gas station Delta-8/9). That ban doesn't take effect for a year and will likely be reversed.
I think it’s a classic sell the news and there will probably be a rebound but this is an EO directing the dea to look into rescheduling medicinal THC formulations, not marijuana products like flowers or dabs etc. Any and all companies operating under state laws are still subject to 280E unless legislation changes that. Anyone who wants to produce schedule 3 THC will need dea licensing and they’ll be producing THC to be compounded in medicines not flower at the dispo.
This is what I've been saying. This administration is not going to support high dose recreational cannabis. Note the focus on "powerful" though. I predict when we get the language changed to allow full spectrum CBD that they are going to make hemp THC beverages legitimate. If they are going to increase the allowable amount of THC per container to allow for full spectrum CBD, then it would be easy to slip in limits that also allow for low dose beverages. This would appease the alcohol industry, while addressing the GOPs primary complaints about potency and smell, while also actually making a splash in terms of expanding consumer access to THC products. Schedule 3 doesn't really change anything about who can access cannabis. Making it so THC drinks are able to be sold in alcohol retail, at sporting events, at concerts, etc. would be noticeable to the general public and reach many new consumers.
Because THC is a generic drug. There is no patent to it. It's like trying to invest in ibuprofen. The only people making money will be the government on taxes and fees. Weed stocks were always a terrible investment, when they become more legalized it actually allows the cartels to use their already established system with less fear and they can undercut the market.
He signed it! Amazing. Most companies have medical licenses as well as recreational! This is positive. I have been struggling with back pain this week, and while I got prescribed anti inflammatories and took a gravol the other night to try to fall asleep for the pain and I couldn't. I had my wife go to the local weed dispensary to get 1:1 THC CBD gummies. I had half of 1 and I slept the best I had in a couple days. "Medical" cannabis or "Recreational" cannabis it can all be used for the same intentions whatever they be. Its pure ignorance on their part.... nonetheless we're headed in the right direction verrryyyy slowllyyyy 🐌 🐌
It dumped because details of the EO were supposedly leaked. If the rumor is true, which we'll find out soon, there's a lot of language about CBD, not THC.
Trump just wants CBD to be prescribeable. Not THC. Lots of bussies getting wrecked. The usual transfer of wealth.
I've been waiting for this for a while - I bought my weed stocks mainly in May / June, earlier in the year. These stocks have been absolutely crushed, and weed stocks seem to go in God-mode rallies every number of years (i.e. 2018, end of 2020, beg of 2021), where the underlying stocks can sometimes 5-10X (perhaps life changing money), and I had a feeling that Trump would eventually reschedule. Also, the latest hemp ban is good for the industry, because companies have been selling hemp with tons of THC for years, so that was taking away business from regular cannabis co's. We still have banking reform that can happen (i.e. being able to use CC to buy weed, and allowing these companies to be able to do business / get loans from major banks), and then the really big one, uplisting onto NYSE / Nasdaq. A lot of people like to buy TLRY, but they don't even benefit from US federal reform. The beneficiaries are the US companies which can only be found on OTC (i.e. GTBIF, TCNNF, VRNO, CURLF, etc.). All in all, I'm roughly around 2-3X on my buys, and am holding longer for more.
What new market? Moving from S1 to S3 won’t mean interstate commerce. Any cannabis* sold in Florida will follow Florida regs. Anything sold in Illinois will follow Illinois regs. You still won’t be able to buy anything medical or otherwise in Tennessee and other similar states. You won’t be able to grow cannabis in Georgia and sell it in Florida. Much less sell Canadian produced products legally in the U.S. The companies that now operate within those frameworks will benefit a lot from 280e going away and we might see other liberalizations that lead to banking and uplisting. Do you see Tilray’s management being able go into areas now dominated by American operators? *I’m leaving low THC hemp exception stuff out of the argument.
Because it will be highly regulated. I have been in the tobacco business myself for 15 years. I do not see any THC being permitted to be sold at gas stations. States that have legalized it are already limited to dispensaries. There’s a reason for this. I may be wrong but I doubt it.
Anything CBD/THC related is going to be a PND today. Trumps announcement isn't going to be as amazing for small cap as people are expecting. The prices will fluctuate a little, jumping up at times, but once the news is released; the only ones who will benefit long term is big pharma. Expect a massive sell-off upon news.
Not sure where you’re pulling those numbers, but they don’t match the tape or fresh filings. Let’s break it down: * **Float**: Your 1.8M is off. Post-rebrand, OS is 2.0M with 2.0M float after adjusting for insider holdings. Tight, but not *that* tight. * **Insider ownership**: 44%? Fresh data shows **2.4%** (48K shares). GTII doesn’t own 700K shares—they sold their brand portfolio to RYM for $50M in August 2025. That’s an acquisition, not a stake. * **Institutions**: 2% total, not 7%. Vanguard, UBS, and Geode hold minor positions. No heavy institutional accumulation. * **Volume**: Today’s volume is \~13% of the 20-day average—23K vs 180K. This isn’t “going crazy,” it’s illiquid and easily pushed around. * **Short interest**: 3.82% (43K shares), borrow fee 5–10%. Not a squeeze setup. * **Dilution overhang**: 7.6M warrants + 6.2M shares issuable on converts = **600% potential dilution**if exercised. That’s the real float risk, not retail FOMO. Your thesis hinges on a misread of the GTII deal and float size. The real play here is a rebranded hemp-THC story with strong cash ($35.6M) but high burn ($10M net loss last quarter). If you’re bullish, it’s on regulatory rescheduling and execution...not on faulty float math. Do your DD with real filings (10-Qs, S-1s) and level-2 data. This isn’t a pump, it’s a volatile small cap with asymmetric risk. Trade accordingly. Arrivederci.
Definitely a major risk factor unless there’s a carve out for intoxicating hemp beverages before next November. I can’t imagine U.S. government allowing “regular” THC in beverages anytime soon as a substitute. A lot of regulations need to be worked out with international and interstate commerce for Tilray/LPs and their infused beverages and medical businesses. Investors might be disappointed when they realize the limitations of rescheduling. Plus the reaction to S3 may not be as extraordinary from a valuation standpoint as most believe it to be.
They have promising "other" drugs and their THC drug has been an ever increasing revenue. It makes up something like 25% but don't quote me on it. Because the revenues are increasing, their profitable and doing buybacks and have the only FDA approved THC drug I figured I'd start a small position.
The thing I am worried about is not whether rescheduling happens. It's whether they are able to separate recreational low-dose products like beverages/gummies from recreational high-dose products like vapes/flower. The few comments he's made directly addressing this talk about "more research". I'm just concerned the focus on more research is going to be looking into the effects of high dosages of THC, and used as a justification to not give high dose recreational products the same market opportunities as low-dose products and medical products. The GOP keeps going after potency/smell as their issues. They've already suggested making SAFE apply to just low-dose products back in 2019. Right now they are in the one-year period to regulate low dose products. They have Congress involved the rescheduling discussions. It makes sense as a time to do this, and I've always thought the regulation of hemp products and rescheduling of cannabis has to happen at the same time (to prevent public confusion). Congress could be involved because they want to make sure they don't reschedule without having some way to restrict how much it would help companies selling high dose recreational products. They've already separated fentanyl into two schedules based on if its medical or recreational (illegal). Obviously state-legal markets shouldn't be seen as "illegal" recreational cannabis markets, but they technically are in the eyes of the federal government. So there is recent precedent for a bifurcation type scenario. You can apply your own % likelihood of something like this happening. I am just trying to temper the over-exuberance that we get during every rumor cycle. There are a lot of ways that even rescheduling doesn't get us everything we need to create a market that the current companies can thrive in long term. We are counting on reform being put in place by many people who have been openly hostile to the idea of high-dose recreational cannabis products.
Cannabix Technologies Inc. (CSE: $BLO) (OTCID: $BLOZF) is a developer of marijuana and alcohol breath technologies for workplaces, law enforcement and other settings. Breath testing for delta-9 THC (the primary psychoactive ingredient in cannabis) focuses on recent marijuana use. Cannabix is the developer of the BreathLogix autonomous alcohol screening device for organizations who strive to improve alcohol safety and monitoring. http://www.cannabixtechnologies.com/
Somewhere between now and early January at the latest, according the MJ Herald. We have heard such promises before however, notably after the infamous "few weeks" comment. It's been reported that Kim Rivers and Howard Kessler (source of the CBD THC video Trump posted on his Truth Social) were there when Cannabis was discussed with house speaker Mike Johnson. Keep in mind the EO was phrased "as early as Monday" not a Shadd Dales powered by Dutchie guarentee of Monday. When? We know it's 100% up to Trump. It will be initiated by executive order that much we do know. Once that kicks off, Bondi and Cole will do as they are told. Trump runs an autocracy in the executive branch.
BHST & CURLF. My guess is king cheeto will "let" his Israeli overlords grow the THC molecules in their bioreactors while his Russian billionaire buddy, Boris Johnson, sells it thru Curaleaf.